Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.01% | -17.23% | -3.60% | 7.53% | 1.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.13% | -6.50% | 12.19% | 22.74% | 15.66% |
| Operating Income | 28.13% | 6.50% | -12.19% | -22.74% | -15.66% |
| Income Before Tax | -17.27% | 36.52% | -955.33% | -163.31% | -151.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.27% | 36.52% | -955.33% | -163.31% | -151.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.27% | 36.52% | -955.33% | -163.31% | -151.32% |
| EBIT | 28.13% | 6.50% | -12.19% | -22.74% | -15.66% |
| EBITDA | 29.30% | 7.10% | -10.97% | -21.56% | -14.21% |
| EPS Basic | 17.24% | 50.10% | -905.83% | -160.35% | -149.48% |
| Normalized Basic EPS | 21.91% | 52.13% | -906.67% | -160.36% | -149.52% |
| EPS Diluted | 17.24% | 50.10% | -905.83% | -164.67% | -149.48% |
| Normalized Diluted EPS | 21.91% | 52.13% | -906.67% | -164.04% | -149.52% |
| Average Basic Shares Outstanding | 41.78% | 27.20% | 4.66% | 4.86% | 3.68% |
| Average Diluted Shares Outstanding | 41.78% | 27.20% | 4.66% | -1.15% | 3.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |